Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Eagle Pharmaceuticals Inc (EGRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2018 Q3 | 213,822 | 0.04 | Reduce 5.53% | <0.01 | $69.33 | $14,824,000 | SEC |
| 2018 Q2 | 226,333 | 0.04 | Reduce 54.82% | 0.04 | $75.66 | $17,124,000 | SEC |
| 2018 Q1 | 500,922 | 0.07 | Reduce 16.72% | 0.01 | $52.69 | $26,394,000 | SEC |
| 2017 Q4 | 601,505 | 0.08 | $53.42 | $32,132,000 | SEC | ||
| 2017 Q3 | 601,505 | 0.08 | Reduce 7.67% | <0.01 | $59.64 | $35,874,000 | SEC |
| 2017 Q2 | 651,505 | 0.12 | Reduce 1.44% | <0.01 | $78.89 | $51,397,000 | SEC |
| 2017 Q1 | 661,005 | 0.14 | Add 4.13% | <0.01 | $82.94 | $54,824,000 | SEC |
| 2016 Q4 | 634,805 | 0.13 | Add 11.72% | 0.01 | $79.34 | $50,365,000 | SEC |
| 2016 Q3 | 568,205 | 0.10 | Buy | 0.10 | $70.00 | $39,774,000 | SEC |